Quanterix Corp (NASDAQ:QTRX) – Leerink Swann issued their FY2017 earnings per share (EPS) estimates for Quanterix in a research note issued on Tuesday, Zacks Investment Research reports. Leerink Swann analyst P. Souda anticipates that the company will earn ($1.17) per share for the year. Leerink Swann has a “Outperform” rating and a $27.00 price objective on the stock. Leerink Swann also issued estimates for Quanterix’s Q4 2017 earnings at ($0.29) EPS, Q1 2018 earnings at ($0.23) EPS, Q2 2018 earnings at ($0.22) EPS, Q3 2018 earnings at ($0.23) EPS, Q4 2018 earnings at ($0.22) EPS, FY2018 earnings at ($0.90) EPS, Q1 2019 earnings at ($0.17) EPS, Q2 2019 earnings at ($0.10) EPS, Q3 2019 earnings at ($0.05) EPS, Q4 2019 earnings at $0.01 EPS, FY2019 earnings at ($0.30) EPS and FY2020 earnings at $0.37 EPS.
A number of other research firms also recently commented on QTRX. BTIG Research initiated coverage on shares of Quanterix in a research report on Tuesday, January 2nd. They set a “buy” rating and a $26.00 price target on the stock. Cowen initiated coverage on shares of Quanterix in a research note on Tuesday, January 2nd. They issued an “outperform” rating on the stock. Finally, JPMorgan Chase & Co. initiated coverage on shares of Quanterix in a research note on Tuesday, January 2nd. They issued an “overweight” rating on the stock.
Quanterix (NASDAQ:QTRX) traded up $0.46 during mid-day trading on Thursday, hitting $20.57. 289,977 shares of the company’s stock were exchanged, compared to its average volume of 241,322. Quanterix has a one year low of $15.56 and a one year high of $23.70. The company has a market cap of $416.43 and a P/E ratio of -13.27.
In other Quanterix news, Director David R. Walt acquired 200,000 shares of the stock in a transaction dated Monday, December 11th. The shares were bought at an average price of $15.00 per share, with a total value of $3,000,000.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider E Kevin Hrusovsky acquired 34,000 shares of the stock in a transaction dated Monday, December 11th. The stock was acquired at an average cost of $15.00 per share, for a total transaction of $510,000.00. The disclosure for this purchase can be found here. Insiders bought a total of 500,000 shares of company stock worth $7,500,000 in the last ninety days.
TRADEMARK VIOLATION WARNING: “FY2017 Earnings Estimate for Quanterix Corp Issued By Leerink Swann (NASDAQ:QTRX)” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/13/research-analysts-set-expectations-for-quanterix-corps-fy2017-earnings-qtrx.html.
Quanterix Corporation is a United States-based company, which is a developer of tools in high definition diagnostics. The Company offers single molecule array (Simoa) platform, whcich uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology.
Get a free copy of the Zacks research report on Quanterix (QTRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.